Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSerco Regulatory News (SRP)

Share Price Information for Serco (SRP)

Share Price is delayed by 15 minutes
Get Live Data
250.20    -3.40 (-1.34%)
Bid:
251.20
Ask:
251.60
Spread: 0.40 (0.159%)
Market Cap: £2.46b
SRP Live PriceLast checked at - London Stock Exchange

Intraday Serco Share Chart

Director/PDMR Shareholding

23 Jun 2020 15:15

RNS Number : 8341Q
Serco Group PLC
23 June 2020
 

23 June 2020

Serco Group plc (the 'Company')

Legal Entity Identifier: 549300PT2CIHYN5GWJ21

 

INITIAL NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMRs') IN ORDINARY SHARES OF 2p EACH IN THE COMPANY ('Ordinary Shares')

 

On 19 June 2020, Kevin Craven exercised nominal-cost options granted under the 2009 Serco Performance Share Plan and, on the same date, sold the full balance of Ordinary Shares acquired.

 

A summary of the Ordinary Shares acquired and sold is set out below.

 

Name of PDMR

Grant date of award

Vest date of award

Number of Ordinary Shares acquired

Ordinary Shares sold

Kevin Craven, CEO, UK & Europe

6 April 2017

6 April 2020

220,000

220,000

 

The price for the disposal of the Ordinary Shares was £1.5425 per Share.

 

This announcement is made in accordance with the requirements of Article 19 of the EU Market Abuse Regulation 596/2014.

 

The notification of dealing forms for these transactions can be found below.

 

Transaction notification

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Kevin Craven

2

 

Reason for the notification

 

a)

 

Position/status

 

CEO, UK & Europe

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Serco Group plc ('the Company')

b)

 

LEI

 

549300PT2CIHYN5GWJ21

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 2 pence each ('Ordinary Shares')

 

Identification code

ISIN: GB0007973794

b)

 

Nature of the transaction

 

 

The exercise of nominal-cost options over Ordinary Shares granted on 6 April 2017 under the Company's 2009 Performance Share Plan.

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£0.02

220,000

d)

 

Aggregated information

- Aggregated volume

220,000

- Price

£4,400

e)

 

Date of the transaction

 

19 June 2020

f)

 

Place of the transaction

N/A

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 2 pence each ('Ordinary Shares')

 

Identification code

ISIN: GB0007973794

b)

 

Nature of the transaction

 

 

The sale of Ordinary Shares following the exercise of nominal-cost options over Ordinary Shares on 19 June 2020 under the Company's 2009 Performance Share Plan.

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£1.5425

220,000

d)

 

Aggregated information

- Aggregated volume

220,000

- Price

£339,350

e)

 

Date of the transaction

 

19 June 2020

f)

 

Place of the transaction

London Stock Exchange (XLON)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUOASRROUNUAR
Date   Source Headline
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20243:47 pmRNSDirector/PDMR Shareholding
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20246:03 pmRNSDirector/PDMR Shareholding
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSDirector/PDMR Shareholding
28th Mar 20245:33 pmRNSTransaction in Own Shares and Total Voting Rights
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
20th Mar 202410:00 amRNSPublication of the 2023 ARA and 2024 Notice of AGM
20th Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSShare Repurchase Programme
4th Mar 20247:00 amRNSSerco completes acquisition of European Homecare
1st Mar 20245:43 pmRNSAnnual Financial Report
29th Feb 20247:00 amRNS2023 Final Results
2nd Feb 20244:33 pmRNSHolding(s) in Company
29th Jan 20244:46 pmRNSHolding(s) in Company
22nd Jan 202411:36 amRNSHolding(s) in Company
29th Dec 202310:00 amRNSTotal Voting Rights
27th Dec 20232:30 pmRNSHolding(s) in Company
14th Dec 20237:00 amRNSAcquisition of leading German immigration business
14th Dec 20237:00 amRNSPre-close trading update
11th Dec 202310:31 amRNSCancellation of Treasury Shares
6th Dec 20231:03 pmRNSDirector Declaration
5th Dec 202312:40 pmRNSHolding(s) in Company
27th Nov 20235:45 pmRNSBlock Listing Application
8th Nov 20237:00 amRNSSerco wins £200m electronic monitoring contract
25th Oct 20237:00 amRNSSerco appoints new CEO in Asia Pacific
20th Oct 20232:02 pmRNSHolding(s) in Company
17th Oct 20237:00 amRNSSerco wins new £350m contract
10th Oct 202312:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.